Nasopharyngeal Carcinoma
📧 Sign up to get email alerts when something new happens for Nasopharyngeal Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-12-10Clinical Trial Update: Study of Combination of Sorafenib With Cisplatin and 5-fluorouracil as First-line Treatment of Recurrence After Radiotherapy Patients Who Failed With Radiotherapy in Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC) [Phase 2]
Phase 2 trial evaluating a combination of sorafenib with cisplatin and 5-fluorouracil as first-line therapy for patients with recurrent or m…
-
CLINICAL_TRIALS research · 2013-10-30Clinical Trial Update: Reproducibility and Reliability of Epstein-Barr Virus (EBV) DNA/RNA Measures in Nasopharyngeal Swabs
This clinical trial update assesses the reproducibility and reliability of EBV DNA/RNA measurements in nasopharyngeal swabs for suspected na…
-
CLINICAL_TRIALS trial_result · 2013-08-13Clinical Trial Update: Study of Chemoradiotherapy Combined With Cetuximab in Nasopharyngeal Carcinoma [Phase 2]
A Phase 2 clinical trial investigating chemoradiotherapy combined with cetuximab for nasopharyngeal carcinoma has completed.
-
CLINICAL_TRIALS research · 2013-07-30Clinical Trial Update: Combination of Cisplatin Plus Gemcitabine Induction Chemotherapy and Intensity-modulated radiotherapyIntensity-modulated Radiotherapy With or Without Concurrent Cisplatin for NPC [Phase 2, Phase 3]
The study investigates induction chemotherapy with cisplatin and gemcitabine plus intensity-modulated radiotherapy, with or without concurre…
-
CLINICAL_TRIALS research · 2013-07-12Clinical Trial Update: Adjuvant Chemotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma [Phase 3]
A Phase 3 clinical trial from Sun Yat-sen University investigates adjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-05-31Clinical Trial Update: Electroacupuncture in Treating Delayed Nausea and Vomiting in Patients Receiving Chemotherapy For Newly Diagnosed Childhood Sarcoma, Neuroblastoma, Nasopharyngeal Cancer, Germ Cell Tumors, or Hodgkin Lymphoma [NA]
This document provides an update on a completed clinical trial evaluating electroacupuncture to treat delayed nausea and vomiting in childre…
-
CLINICAL_TRIALS research · 2013-04-12Clinical Trial Update: Study of DC-CIK to Treat NPC [Phase 2]
Ongoing Phase 2 clinical trial evaluating DC-CIK therapy for nasopharyngeal carcinoma.
-
CLINICAL_TRIALS research · 2013-03-12Clinical Trial Update: Recombine Endostatin With Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiation in Advanced Nasopharynx Cancer [Phase 2, Phase 3]
This is a Phase 2/3 clinical trial update evaluating recombinant endostatin with neoadjuvant chemotherapy followed by concurrent chemoradiat…
-
CLINICAL_TRIALS trial_result · 2013-03-05Clinical Trial Update: Efficacy Study of Neoadjuvant Chemotherapy With Chemoradiation Therapy for Nasopharyngeal Carcinoma [Phase 3]
Phase 3 clinical trial evaluating the efficacy of neoadjuvant chemotherapy combined with chemoradiation therapy for nasopharyngeal carcinoma…
-
CLINICAL_TRIALS research · 2013-02-26Clinical Trial Update: Dysphagia Rehabilitation for Nasopharyngeal Carcinoma Patients Post Radiotherapy [NA]
This entry documents an ongoing clinical trial evaluating dysphagia rehabilitation in patients with nasopharyngeal carcinoma after radiother…
-
CLINICAL_TRIALS trial_result · 2012-10-10Clinical Trial Update: T-Lymphocytes in Treating Patients With Epstein-Barr Virus-Positive Nasopharyngeal Cancer, NPC [Phase 1]
Phase 1 trial evaluating EBV-specific cytotoxic T lymphocytes for Epstein-Barr virus-positive nasopharyngeal carcinoma; study status is comp…
-
CLINICAL_TRIALS research · 2012-08-21Clinical Trial Update: Late-Course Accelerated Hyperfractionated IMRT for Locoregionally Advanced Nasopharyngeal Carcinoma [Phase 2, Phase 3]
Clinical trial update noting completion of a Phase 2/3 study evaluating late-course accelerated hyperfractionated IMRT for locoregionally ad…
-
CLINICAL_TRIALS trial_result · 2012-08-02Clinical Trial Update: GC Regimen Chemotherapy Plus CIK Cells for Metastatic Nasopharyngeal Carcinoma [Phase 2]
An update on a Phase 2 trial evaluating GC regimen chemotherapy plus CIK cells for Stage IV nasopharyngeal carcinoma; the trial status is un…
-
CLINICAL_TRIALS trial_result · 2012-07-30Clinical Trial Update: EBV-Specific CTLs Following CD45 Antibody to Patients With Epstein-Barr Virus (EBV) + Nasopharyngeal Carcinoma (NPC) [Phase 1]
Phase 1 trial evaluating EBV-specific cytotoxic T lymphocytes following a CD45 antibody in patients with EBV-positive nasopharyngeal carcino…
-
CLINICAL_TRIALS research · 2012-06-08Clinical Trial Update: Induction Chemotherapy Followed by Concurrent Radiation With Cetuximab or Cisplatin in Locally Advanced Nasopharyngeal Cancer [Phase 2]
A Phase 2 clinical trial evaluating induction chemotherapy followed by concurrent radiation with either cetuximab or cisplatin in locally ad…
-
CLINICAL_TRIALS withdrawal · 2012-04-16Clinical Trial Update: Study of LMP1- and LMP2- Specific Cytotoxic T-Lymphocytes (CTL) [Phase 1]
A Phase 1 trial evaluating LMP1- and LMP2-specific cytotoxic T lymphocytes for nasopharyngeal carcinoma has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2012-04-02Clinical Trial Update: A Study Of Nasopharyngeal Carcinoma (NPC) Treated With Celecoxib And ZD1839 [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial in Singapore evaluated the combination of celecoxib and gefitinib for nasopharyngeal carcinoma.
-
CLINICAL_TRIALS trial_result · 2012-02-16Clinical Trial Update: Study of Alimta in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC) Who Have Had Prior Platinum Based Chemotherapy [Phase 2]
Phase 2 trial evaluating pemetrexed (Alimta) in patients with recurrent or metastatic nasopharyngeal carcinoma after platinum-based chemothe…
-
CLINICAL_TRIALS research · 2011-12-22Clinical Trial Update: Modified Vaccinia Ankara (MVA) Vaccine Study [Phase 1]
A Phase 1 study of a Modified Vaccinia Ankara (MVA) vaccine for nasopharyngeal carcinoma and Epstein-Barr virus infection has completed.
-
CLINICAL_TRIALS trial_result · 2011-11-28Clinical Trial Update: A Multicenter Trial Evaluating the Efficacy of Nedaplatin in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma [Phase 3]
Phase 3 multicenter trial evaluating nedaplatin for locoregionally advanced nasopharyngeal carcinoma, sponsored by Guangxi Medical Universit…
-
CLINICAL_TRIALS trial_result · 2011-10-10Clinical Trial Update: Clinical Study of EBV-LMP1 Targeted DNAzyme to Treat Nasopharyngeal Carcinoma [Phase 1, Phase 2]
A Phase 1/2 clinical study evaluating an EBV-LMP1 targeted DNAzyme for nasopharyngeal carcinoma has completed (Phase 1 and Phase 2) under Xi…
-
CLINICAL_TRIALS research · 2011-09-19Clinical Trial Update: Environmental and Genetic Determinants of Nasopharyngeal Carcinoma (NPC)
This clinical trial explores environmental and genetic determinants of nasopharyngeal carcinoma, sponsored by Far Eastern Memorial Hospital.
-
CLINICAL_TRIALS trial_result · 2011-07-08Clinical Trial Update: Foscan®-Mediated Photodynamic Therapy Versus Brachytherapy in Patients With Nasopharyngeal Carcinoma [Phase 2]
A Phase 2 clinical trial comparing Foscan-mediated photodynamic therapy to brachytherapy in nasopharyngeal carcinoma; the current status of …
-
CLINICAL_TRIALS research · 2011-06-16Clinical Trial Update: Benefit of Adding Chemotherapy And/Or Modification of Radiotherapy Schedule for Advance Nasopharyngeal Carcinoma (T3-4N0-1M0) [NA]
This clinical trial update discusses potential benefit of adding chemotherapy and/or modifying radiotherapy schedules for advanced nasophary…
-
CLINICAL_TRIALS trial_result · 2011-03-10Clinical Trial Update: Weekly Docetaxel Plus Cisplatin as the First-line Therapy for Nasopharyngeal Cancer [Phase 2]
Phase 2 clinical trial evaluating weekly docetaxel plus cisplatin as first-line therapy for nasopharyngeal carcinoma. The status of the tria…